Nanosphere Health Sciences (STU:2CG2) ROCE % : 0.00% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Nanosphere Health Sciences ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nanosphere Health Sciences's annualized ROCE % for the quarter that ended in Sep. 2024 was 0.00%.

Nanosphere Health Sciences ROCE % Historical Data

The historical data trend for Nanosphere Health Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere Health Sciences ROCE % Chart

Nanosphere Health Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

Nanosphere Health Sciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Nanosphere Health Sciences ROCE % Calculation

Nanosphere Health Sciences's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.217	/	( ( (0.057 - 1.295)	+	(0.017 - 1.443) )	/ 2 )
	=	-0.217	/	( (-1.238	+	-1.426)	/ 2 )
	=	-0.217	/	-1.332
	=	16.29 %

Nanosphere Health Sciences's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-0.148	/	( ( (0.031 - 1.544)	+	(0.021 - 1.538) )	/ 2 )
	=	-0.148	/	( ( -1.513	+	-1.517 )	/ 2 )
	=	-0.148	/	-1.515
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Nanosphere Health Sciences (STU:2CG2) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nanosphere Health Sciences ROCE % Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosphere Health Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (STU:2CG2) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

NSHSF:USA NSHS:Canada

Address

1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7

Website

http://www.nanospherehealth.com

Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.

Nanosphere Health Sciences Headlines

No Headlines